Примери за използване на Primary efficacy endpoint на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Primary efficacy endpoint.
Responders for the Primary Efficacy Endpoint.
Primary efficacy endpoint OS.
The IVCM total score was the primary efficacy endpoint.
The primary efficacy endpoint was OS.
In the 20-week study(n= 225),no significant difference was observed in the primary efficacy endpoint, i.e.
The primary efficacy endpoint was overall survival.
These studies were of poor methodological quality: uncontrolled,open designed and without any well-defined primary efficacy endpoint.
The primary efficacy endpoint was ORR according to RECIST.
Time to First Occurrence of Primary Efficacy Endpoint(CV death, MI or stroke).
The primary efficacy endpoint was number of oocytes retrieved.
The rate of moderate orsevere COPD exacerbations per patient per year during the first year of treatment was evaluated as the primary efficacy endpoint in the study.
The primary efficacy endpoint was vital pregnancy rate.
Change in SEGA volume during the core 6-month treatment phase, as assessed via an independent central radiology review,was the primary efficacy endpoint.
The primary efficacy endpoint was 1-year survival rate.
In both studies the primary efficacy endpoint was evaluated at 52 weeks.
The primary efficacy endpoint was the composite of stroke and SEE.
In all short-term studies, the primary efficacy endpoint was change in MADRS total score from baseline to day 28.
The primary efficacy endpoint was the ASAS20 response rate at Week 12.
Serum antiHBs trough levels of 100 IU/l and higher(primary efficacy endpoint) were maintained for all patients during the 18 to 24 week trial period.
The primary efficacy endpoint was absolute change in LCI2.5 from baseline through Week 24.
The primary efficacy endpoint was overall survival(OS).
The primary efficacy endpoint in both studies was‘time to treatment failure'.
The primary efficacy endpoint was mean change in BCVA from baseline to week 52.
The primary efficacy endpoint in both studies was the absolute change from baseline in ppFEV1 at week 24.
The primary efficacy endpoint was the intraocular pressure(IOP) change from baseline at Week 12 of the study.
The primary efficacy endpoint was angiomyolipoma response rate based on independent central radiology review.
The primary efficacy endpoint was the SLE Responder Index(SRI) at Week 52 as described in the adult intravenous trials.
Primary efficacy endpoint(International Myeloma Working Group criteria) CI=confidence interval; NE=not estimable; MR=minimal response.
The primary efficacy endpoint was the numbers of meters walked in 12 minutes at Week 24 compared to the number of meters walked at baseline.